abstract |
The present invention relates to pharmaceutical formulations comprising acid stabi- lized insulin, and a salt of protamine or other positively charged peptides, to methods of pre- paring such formulations, and to uses of such formulations in the treatment of diseases and conditions for which use of the insulin peptide(s) contained in such formulations is indicated. |